Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Hedge Funds

Hedge Funds

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • General
  • Hedge Funds
  • Media
  • News
  • Short Sellers

GameStop Short Seller Melvin Capital Ended 2021 First-Half With 46% Loss: Report

By Madhukumar Warrier
Today, 9:14 PM
GameStop Corp. (NYSE: GME) short seller Melvin Capital Management LP ended the first half of 2021 with a loss of 46%, Bloomberg reported Thursday, citing people familiar wi

AMC

Read More
1 minute read
  • General
  • Hedge Funds
  • Trading Ideas

Cathie Wood’s ARK Invest Posts Fund Sales For Wednesday, July 7, 2021: SE, PSTI, CSTL, CDNA, BMY, TXG, TCEHY, ROKU, PSTG, NVS, IOVA, ICE, BEKE, RAVN, HUYA, LC

By Michael Horton
Today, 9:14 PM
Sea (SE) - 54,753 Shares Pluristem Therapeutics (PSTI) - 1,197 Castle Biosciences (CSTL) - 20,378 CareDx (CDNA) - 7,500 Bristol-Myers Squibb (BMY) - 69,853 10x Genomics (TXG) - 89,450 Tencent (TCEHY) -

BEKE

Read More
1 minute read
  • General
  • Hedge Funds
  • Trading Ideas

Cathie Wood’s ARK Invest Posts Fund Purchases For Wednesday, July 7, 2021: PATH, SGFY, RXRX, RPTX, QSI, MASS, FATE, COIN, TSLA, VUZI, FTCH, AVAV

By Michael Horton
Today, 9:14 PM
UiPath (PATH) - 440,157 Shares Signify Health (SGFY) - 53,916 Recursion Pharmaceuticals (RXRX) - 204,752 Repare Therapeutics (RPTX) - 18,190 Quantum-Si (QSI) - 359,389 908 Devices (MASS) - 47,945 Fate

AVAV

Read More
1 minute read
  • General
  • Hedge Funds

GeoPark Shareholder Gerald O’Shaughnessy Issues Letter Recommending Shareholders Vote Against Co. Nominees At Upcoming Annual Meeting

By Bill Haddad
Today, 9:14 PM
Company's Board Has Failed to Address Pressing Strategic Challenges that Will Impede Future Value Creation GeoPark's Public Materials Contain Numerous Outright Lies – Including About Mr.

GPRK

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Hedge Funds
  • Management
  • News

GlaxoSmithKline’s Board Backs CEO Walmsley After Elliott’s Letter For Management Shakeup

By Vandana Singh
Today, 9:14 PM
GlaxoSmithKline plc (NYSE:GSK) said its board sees Chief Executive Emma Walmsley as the right person to lead its pharmaceutical business after…

GSK

Read More
1 minute read
  • General
  • Hedge Funds
  • Trading Ideas

Cathie Wood’s ARK Invest Posts Fund Sales For Thursday, July 1, 2021: CDNA, PSTI, GLEO, LC, PD, ROKU

By Michael Horton
Today, 9:14 PM
CareDx (CDNA) - 20,399 Shares Pluristem Therapeutics (PSTI) - 1,493 Galileo Acquisition (GLEO) - 400 LendingClub (LC) - 69,917 PagerDuty (PD) - 114,600 Roku (ROKU) - 25,300

CDNA

Read More
1 minute read
  • General
  • Hedge Funds
  • Trading Ideas

Cathie Wood’s ARK Invest Posts Fund Purchases For Thursday, July 1, 2021: QSI, SEER, BZ, VUZI

By Michael Horton
Today, 9:14 PM
Quantum-Si (QSI) - 350,312 Shares Seer (SEER) - 52,532 KANZHUN (BZ) - 242,938 Vuzix (VUZI) - 354,128  

BZ

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Hedge Funds
  • Management
  • News

Activist Fund Elliott Management Wants GlaxoSmithKline Board Shakeup For ‘Years Of Under Management’

By Vandana Singh
Today, 9:14 PM
Elliott Management has finally made its intentions around GlaxoSmithKline plc (NYSE: GSK) known and calls for changes to rescue GSK from what it called "years of under-management."

GSK

Read More
1 minute read
  • General
  • Hedge Funds
  • Trading Ideas

Cathie Wood’s ARK Invest Posts Fund Sales For Wednesday, June 30, 2021: CSTL, PSTI, RAVN, GLEO, LC, PLTR

By Michael Horton
Today, 9:14 PM
Castle Biosciences (CSTL) - 26,900 Shares Pluristem Therapeutics (PSTI) - 1,679 Raven Industries (RAVN) - 116,575 Galileo Acquisition (GLEO) - 1,600 LendingClub (LC) - 158,535 Palantir Technologies (PLTR) -

CSTL

Read More
1 minute read
  • General
  • Hedge Funds
  • Trading Ideas

Cathie Wood’s ARK Invest Posts Fund Purchases For Wednesday, June 30, 2021: QSI, PATH, BZ, VUZI

By Michael Horton
Today, 9:14 PM
Quantum-Si (QSI) - 266,687 Shares UiPath (PATH) - 427,182 KANZHUN (BZ) - 481,408 Vuzix (VUZI) - 303,763

BZ

Posts navigation

Previous 1 … 40 41 42 … 44 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service